Mark is a Managing Director in the M&A group and Head of Real Estate Investment Banking, with experience in public and private M&A transactions as well as broader advisory mandates across various industries, including healthcare, real estate, technology, and diversified industries. Mark has completed in excess of $15 billion of M&A/advisory transactions across various industries and structures, including domestic, cross border, hostile and friendly transactions. Mark holds a Bachelor of Arts (Economics) and a Master of Business Administration, both from Cornell University.
Selected Transactions
-
C$491m
Emmac Life Sciences PLC
Financial Advisor to Emmac Life Sciences PLC on its sale to Curaleaf
-
C$310m
Columbia Care
Financial Advisor to Columbia Care on its acquisition of Green Leaf Medical
-
C$78m
Starseed
Financial Advisor on acquisition by WeedMD
-
N/a
Stockhouse
Financial Advisor to Stockhouse on its sale to HotCopper
-
C$2b
Cura Partners
Financial Advisor on Acquisition by Curaleaf
-
C$936m
Cresco
Financial Advisor on acquisition of Origin House
-
C$785m
Nuuvera
Financial Advisor to Nuuvera on its sale to Aphria
